News

Advocacy Groups Oppose Additional Trial for DCCR

The Foundation for Prader-Willi Research (FPWR) and the Prader-Willi Syndrome Association (PWSA) in the U.S. have asked the U.S. Food and Drug Administration (FDA) to reconsider its request for an additional clinical trial of diazoxide choline controlled release (DCCR) tablets in patients with Prader-Willi syndrome (PWS). Last month, the…

Sleep Issues Common, Rarely Addressed, White Paper Asserts

People with Prader-Willi syndrome (PWS) and other diseases commonly experience sleep problems, and the problems are rarely addressed effectively by healthcare professionals, according to a white paper published by Harmony Biosciences. Excessive daytime sleepiness, or EDS, is a common symptom experienced by people with rare diseases…

Protein-rich Diet May Help Control Weight in PWS Youth

Consumption of a high-protein diet shifts muscle cells’ metabolism to use fats rather than carbohydrates as an energy source in children and young adults with Prader-Willi syndrome (PWS), a pilot study in Canada suggests. The findings support the need for more studies to assess the implications of different types…

Adults With PWS Have Unique Gut Bacteria

Adults with Prader-Willi syndrome (PWS) have a unique gut bacteria composition, characterized by low levels of probiotic species and a high number of other microbes whose potential health and metabolic implications are still unknown, a study has found. The findings indicate that people with PWS may benefit from probiotic…